ClinicalTrials.gov
public full text
Public Domain
Calcium Channel Blockade in Primary Aldosteronism
This pilot study explore whether the calcium channel blocker amlodipine can lower aldosterone levels in people with primary aldosteronism.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Calcium Channel Blocker in Myotonic Dystrophy Type 1#859982
- RAS Blockade at Bedtime Versus on Awakening for Aldosterone Breakthrough#832061
- A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure#906189
- The interactive effect of long nighttime sleep and daytime napping on QTc prolongation in hypertensive adults.#1007
- Data for Manuscript: Osmolarity controls oscillatory calcium signaling to reduce autonomous aldosterone production in zona glomerulosa cells#1028158
Record · ID 832886
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive